---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-007902"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-02-21T23:59:59+00:00"
generated_at: "2026-05-26T06:56:18.233471+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PAVmed raises $2.37M via PIPE of common stock and pre-funded warrants with Veris subsidiary shares

## Summary
- Sale of 2,574,350 shares and 756,734 pre-funded warrants at $0.7115/unit; Veris issues 677,143 shares to investors.
- Gross proceeds of $2.37M; proceeds to fund Veris' implantable physiological monitor and working capital.
- Company grants anti-dilution protection via additional Veris shares; restricts indebtedness until Aug 18, 2026.
- Registration rights granted; stockholder vote required for warrant shares by June 30, 2025.
- Transaction exempt under Section 4(a)(2) and Regulation D; no public offering.

## SEC filing metadata
- accession: 0001493152-25-007902
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315225007902/0001493152-25-007902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315225007902/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-007902
- JSON: https://secwatch.observer/filing/0001493152-25-007902.json
- Plain text: https://secwatch.observer/filing/0001493152-25-007902.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.